Dr. Echo E. Tan, MD

Dr. Tan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Tan's NPI, 1427373323, was assigned on April 2, 2010. Dr. Tan graduated from New York Medical College in 2010. Dr. Tan's California license number on file is A118776.

Dr. Tan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Tan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Tan is also affiliated with Huntington Hospital. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Tan to 1 more hospital, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tan practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tan is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Tan has a license on file in California.

Dmand AI lists essential tremor, hereditary polyneuropathy, lower back pain, mobility impairment, neuropathy, parkinson's disease, restless legs syndrome and sleep apnea among the conditions Dr. Tan treats.

CMS data shows 1,180 Medicare services from Dr. Tan across 15 procedure codes in 2024, for 277 Medicare patients. Medicare paid $71,318 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Tan in 2026. The largest group is 75 to 84, with 112 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tan's median patient age at 72, with 50% women.

In 2026, Dr. Tan wrote 1,785 Medicare Part D claims for 224 patients. 85% of them were for generic drugs. CMS names the drug for 1,590 of them, across 34 drugs with 11 or more claims each, at $710,303 in total drug cost. In 2023, CMS named 1,424 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Tan for performance year 2026, reported as part of a group. Dr. Tan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tan as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Tan in 2014. Dr. Tan's most frequent co-authors are Michele Tagliati, MD, Elliot Hogg, MD and Helia Maghzi, MD.

CMS Open Payments shows 152 general payments to Dr. Tan from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Abbvie Inc. paid the most, $38,073.

Dr. Tan graduated from New York Medical College in 2010.

Dr. Tan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.